Methylene Blue MMX 25 mg modified release tablets
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Staining in Preparation for Colonoscopy
Conditions
Colon Staining in Preparation for Colonoscopy
Trial Timeline
May 2, 2011 → Jan 16, 2012
NCT ID
NCT03287219About Methylene Blue MMX 25 mg modified release tablets
Methylene Blue MMX 25 mg modified release tablets is a phase 2 stage product being developed by Cosmo Pharmaceuticals for Colon Staining in Preparation for Colonoscopy. The current trial status is completed. This product is registered under clinical trial identifier NCT03287219. Target conditions include Colon Staining in Preparation for Colonoscopy.
What happened to similar drugs?
4 of 14 similar drugs in Colon Staining in Preparation for Colonoscopy were approved
Approved (4) Terminated (5) Active (6)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03287219 | Phase 2 | Completed |
Competing Products
20 competing products in Colon Staining in Preparation for Colonoscopy